The chronic care for wet age related macular degeneration (CHARMED) study: A randomized controlled trial

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Markun, Stefan ^a   Dishy, Avraham ^b   Neuner Jehle, Stefan ^a   Rosemann, Thomas ^a   Frei, Anja ^a,c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b CANTONAL HOSPITAL AARAU   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AGE RELATED MACULAR DEGENERATION; AGED; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DECISION SUPPORT SYSTEM; EVIDENCE BASED MEDICINE; FEMALE; FOLLOW UP; HEALTH CARE ORGANIZATION; HUMAN; MACULAR THICKNESS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PATIENT CARE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SELF MONITORING; VISUAL ACUITY; CLINICAL TRIAL; MACULAR DEGENERATION; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; RETINA; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; QUALITY OF LIFE; RETINA; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84957108384     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0143085     Document Type: Article

References (26)

1. Bressler NM. Age-related macular degeneration is the leading cause of blindness. JAMA. 2004 Apr 21; 291(15):1900-1. PMID: 15108691.
2. Friedman DS, O'Colmain BJ, Munoz B, Tomany SC, McCarty C, de Jong PT, et al. Prevalence of agerelated macular degeneration in the United States. Arch Ophthalmol. 2004 Apr; 122(4):564-72. PMID: 15078675.
3. Solomon SD, Lindsley K, Vedula SS, Krzystolik MG, Hawkins BS. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2014; 8: CD005139. PMID: 25170575. doi: 10.1002/14651858.CD005139.pub3
4. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006 Oct 5; 355(14):1419-31. PMID: 17021318.
5. Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006 Oct 5; 355(14):1432-44. PMID: 17021319. Epub 2006/10/06. eng.
6. Heier JS, Brown DM, Chong V, Korobelnik JF, Kaiser PK, Nguyen QD, et al. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology. 2012 Dec; 119(12):2537-48. PMID: 23084240. doi: 10.1016/j.ophtha.2012.09.006
7. The neovascular age-related macular degeneration database: multicenter study of 92 976 ranibizumab injections: report 1: visual acuity. Ophthalmology. 2014 May; 121(5):1092-101. PMID: 24461586. Epub 2014/01/28. eng. doi: 10.1016/j.ophtha.2013.11.031
8. Rasmussen A, Bloch SB, Fuchs J, Hansen LH, Larsen M, LaCour M, et al. A 4-Year Longitudinal Study of 555 Patients Treated with Ranibizumab for Neovascular Age-related Macular Degeneration. Ophthalmology. 2013; 120(12):2630-6. doi: 10.1016/j.ophtha.2013.05.018 PMID: 23830760
9. Lalwani GA, Rosenfeld PJ, Fung AE, Dubovy SR, Michels S, Feuer W, et al. A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. American journal of ophthalmology. 2009 Jul; 148(1):43-58.e1. PMID: 19376495. doi: 10.1016/j.ajo.2009.01.024
10. Spaide R. Ranibizumab according to need: a treatment for age-related macular degeneration. American journal of ophthalmology. 2007 Apr; 143(4):679-80. PMID: 17386275.
11. Rauch R, Weingessel B, Maca SM, Vecsei-Marlovits PV. Time to first treatment: The significance of early treatment of exudative age-related macular degeneration. Retina. 2012 Jul; 32(7):1260-4. PMID: 22186738. Epub 2011/12/22. eng. doi: 10.1097/IAE.0b013e3182018df6
12. Schmidt-Erfurth U, Chong V, Loewenstein A, Larsen M, Souied E, Schlingemann R, et al. Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA). Br J Ophthalmol. 2014 Sep; 98(9):1144-67. PMID: 25136079. Pubmed Central PMCID: 4145443. doi: 10.1136/bjophthalmol-2014-305702
13. Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A. Improving chronic illness care: translating evidence into action. Health Aff (Millwood). 2001 Nov-Dec; 20(6):64-78. PMID: 11816692. Epub 2002/01/31. eng.
14. Stellefson M, Dipnarine K, Stopka C. The chronic care model and diabetes management in US primary care settings: a systematic review. Prev Chronic Dis. 2013 Feb; 10:E26. PMID: 23428085. Pubmed Central PMCID: 3604796. Epub 2013/02/23. eng. doi: 10.5888/pcd10.120180
15. Adams SG, Smith PK, Allan PF, Anzueto A, Pugh JA, Cornell JE. Systematic review of the chronic care model in chronic obstructive pulmonary disease prevention and management. Archives of internal medicine. 2007 Mar 26; 167(6):551-61. PMID: 17389286.
16. Moullec G, Gour-Provencal G, Bacon SL, Campbell TS, Lavoie KL. Efficacy of interventions to improve adherence to inhaled corticosteroids in adult asthmatics: impact of using components of the chronic care model. Respiratory medicine. 2012 Sep; 106(9):1211-25. PMID: 22770682. doi: 10.1016/j.rmed. 2012.06.001
17. Woltmann E, Grogan-Kaylor A, Perron B, Georges H, Kilbourne AM, Bauer MS. Comparative effectiveness of collaborative chronic care models for mental health conditions across primary, specialty, and behavioral health care settings: systematic review and meta-analysis. The American journal of psychiatry. 2012 Aug; 169(8):790-804. PMID: 22772364. doi: 10.1176/appi.ajp.2012.11111616
18. Epping-Jordan JE. Innovative Care for Chronic Conditions. World Health Organization. 2001. Available: http://www.who.int/chp/knowledge/publications/icccmeeting.pdf
19. Group AHSR, Chew EY, Clemons TE, Bressler SB, Elman MJ, Danis RP, et al. Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the Eye (HOME) study. Ophthalmology. 2014 Feb; 121(2):535-44. PMID: 24211172. Pubmed Central PMCID: 3918479. doi: 10.1016/j.ophtha.2013.10.027
20. Frei A, Woitzek K, Wang M, Held U, Rosemann T. The chronic care for age-related macular degeneration study (CHARMED): study protocol for a randomized controlled trial. Trials. 2011; 12:221. PMID: 21985296. Pubmed Central PMCID: 3214138. Epub 2011/10/12. eng. doi: 10.1186/1745-6215-12-221
21. Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001 Jul; 119(7):1050-8. PMID: 11448327. Epub 2001/07/27. eng.
22. Glasgow RE, Wagner EH, Schaefer J, Mahoney LD, Reid RJ, Greene SM. Development and validation of the Patient Assessment of Chronic Illness Care (PACIC). Med Care. 2005 May; 43(5):436-44. PMID: 15838407. Epub 2005/04/20. eng.
23. Bonomi AE, Wagner EH, Glasgow RE, VonKorff M. Assessment of chronic illness care (ACIC): a practical tool to measure quality improvement. Health Serv Res. 2002 Jun; 37(3):791-820. PMID: 12132606. Pubmed Central PMCID: 1434662. Epub 2002/07/23. eng.
24. Gupta B, Adewoyin T, Patel SK, Sivaprasad S. Comparison of two intravitreal ranibizumab treatment schedules for neovascular age-related macular degeneration. Br J Ophthalmol. 2011 Mar; 95(3):386-90. PMID: 20693484. doi: 10.1136/bjo.2010.179499
25. Subramanian ML, Ness S, Abedi G, Ahmed E, Daly M, Feinberg E, et al. Bevacizumab vs ranibizumab for age-related macular degeneration: early results of a prospective double-masked, randomized clinical trial. American journal of ophthalmology. 2009 Dec; 148(6):875-82.e1. PMID: 19800611. doi: 10. 1016/j.ajo.2009.07.009
26. Markun S, Brandle E, Dishy A, Rosemann T, Frei A. The concordance of care for age related macular degeneration with the chronic care model: a multi-centered cross-sectional study. PloS one. 2014; 9 (10):e108536. PMID: 25290915. Pubmed Central PMCID: 4188520. doi: 10.1371/journal.pone. 0108536